Integra Holdings

Integra Holdings Overview

Integra Holdings is a healthcare investment company with an exclusive first right to examine the innovations and intellectual property emerging from the world-renowned Hebrew University of Jerusalem. With a focus on biopharmaceuticals and medical diagnostics and devices, Integra employs multidisciplinary teams of experts who work alongside inventors and take a hands-on approach to achieve commercial success. Integra provides know-how and support to its portfolio companies from inception to commercialization, while leveraging its extensive industry network cultivated over decades of experience. The company holds a diversified portfolio of companies in the early to late stages, with established partnerships with investment funds such as OrbiMed, Pontifax, Lundbeck fund, SR One, CBI, and BioLight Life Sciences, as well as networks of private investors. Integra Holdings was founded by Yissum, the technology transfer company of the Hebrew University of Jerusalem. Its shareholders include Yissum, Temasek, Invatech Holdings, Arie Capital, Guangxi Wuzhou Pharmaceutical Group Co Ltd, and Israeli Institutional funds, including the Israeli Teachers and Kindergarten Study funds, the Hebrew University Provident Fund, and Halman-Aldubi Investment Group.

Latest News

Oct 23, 2019 · www.drugdiscoveryonline.com

growth-positive

Evotec, Integra Holdings And Yissum Establish LAB555 To Fast Track Early-Stage Drug Development

Evotec SE has announced the inauguration of LAB555, an academic BRIDGE partnership with Integra Holdings and Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem. The partnership aims to expedite drug discovery and development by providing efficient translation of early-stage Hebrew University research. LAB555 leverages the innovation expertise of Integra Holdings and Yissum, with access to Evotecs industrial drug development platform. The partnership aims to accelerate multiple academic research projects to value inflection points and create company spin-outs focused on the development of first-in-class therapeutics.

Partners

Sep 27, 2017 · www.globes.co.il

growth-positive

Life science investment co Integra raises $25m

Integra Holdings, an Israeli company that invests in life science innovations from the Hebrew University of Jerusalem, has announced the first closing of a $25 million financing round. The round was led by Temasek, a Singapore-based investment company, which invested $15 million. Arie Capital, a UK-based firm, also participated with an initial investment of $2 million. The funds raised will be used to advance Integra Holdings portfolio companies and create new companies based on technologies developed at the Hebrew University. This brings the total raised by the fund to $40 million over five years. Yissum, the Technology Transfer Company of the Hebrew University, is another major investor in Integra Holdings.

Investment

Dec 9, 2014 · www.integra-holdings.com

growth-positive

Integra Holdings Closes $3 Million Investment from Guangxi Wuzhou Pharmaceutical Group

Integra Holdings, a biotechnology holdings company, has received a $3 million investment from Guangxi Wuzhou Pharmaceutical Group. The funds will be used to advance Integra Holdings existing portfolio companies and create new companies based on projects from the Hebrew University. Integra Holdings has a portfolio of companies in various therapeutic areas and has raised a total of $12 million to date. The investment from Guangxi Wuzhou Pharmaceutical Group will also help introduce biotech products and technologies to the Chinese market. This investment has doubled Integra Holdings original valuation.

Investment

Team Members

2

Web & Social Links

Locations

Derech Menachem Begin 132, Tel Aviv-Yafo, Israel

Photos & Videos

No files yet

Integra Holdings Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info